PULSE: Phenobarbital as First Line in Alcohol Withdrawal: Is it Worth a Shot - March 3, 2021

March 3, 2021

New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.

Target Audience

Pharmacist

Learning Objectives

  1. Describe the pathophysiology and the associated complication of alcohol withdrawal (AWS)
  2. Discuss three studies that compare the safety and efficacy of phenobarbital versus benzodiazepines as the treatment choice for AWS
  3. Identify an appropriate treatment approach for an AWS patient
Course summary
Available credit: 
  • 1.00 ACPE Pharmacy
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
Course opens: 
03/03/2021
Course expires: 
04/03/2021
Event starts: 
03/03/2021 - 1:30pm EST
Event ends: 
03/03/2021 - 2:30pm EST
Add to calendar: 

New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.

UPMC Presbyterian
Pittsburgh, PA
United States

Jenna Christner, PharmD
PGY1 Pharmacy Resident
UPMC Shadyside

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team

Available Credit

  • 1.00 ACPE Pharmacy
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
Please login or register to take this course.